Revenue
2020
2021
2024
2025
Incannex Healthcare Inc. (IXHL)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $86,000 | $12,000 | — | — | $1.9M | $604,884 |
| Research & development | $10.7M | $12.9M | $6.3M | $5.4M | $4.7M | $2.1M |
| Operating expenses | $23.9M | $30.1M | $49.7M | $15.7M | $13.3M | — |
| Operating income | −$23.8M | −$30.0M | −$49.7M | — | — | — |
| EBITDAderived | −$23.5M | −$29.9M | −$49.6M | — | — | — |
| Net income | −$46.9M | −$18.5M | −$48.8M | −$14.9M | −$11.4M | −$4.7M |
| Basic EPSper diluted share | -$1.35 | -$1.15 | -$3.32 | -$1.25 | -$1.16 | -$0.69 |
| Diluted EPSper diluted share | -$1.35 | -$1.15 | -$3.32 | -$1.25 | -$1.16 | -$0.57 |